References
- Barbour, E. K., Al Sharif, M., Sagherian, V. K., Habre, A. N., Talhouk, R. S. and Talhouk, S. N. (2004) Screening of selected indigenous plants of Lebanon for antimicrobial activity. J. Ethnopharmacol. 93: 1-7 https://doi.org/10.1016/j.jep.2004.02.027
- Jiang su new medical college (1977) Encyclopedia of Chinese Medicinal Substances. Shanghai Peoples Publisher, Shanghai, p. 1502
- Fujimoto T., Hano Y., Nomura T. and Uzawa J. (1984) Components of root bark of Cudrania tricuspidata 2. Structures of two new isoprenylated flavones, cudraflavones A and B. Planta. Med. 50: 161-163 https://doi.org/10.1055/s-2007-969660
- An, R. B., Sohn, D. H. and Kim, Y. C. (2006) Hepato-protective compounds of the roots of Cudrania tricuspidata on tacrine-induced cytotoxicity in Hep G2 cells. Biol. Pharm. Bull. 29: 838-840 https://doi.org/10.1248/bpb.29.838
- Hano, Y., Matsumoto, Y., Sun, J. Y. and Nomura, T. (1990) Structures of four new isoprenylated xanthones, cudraxanthones h, i, j, and k. Planta. Med. 56: 478-481 https://doi.org/10.1055/s-2006-961016
- Zou, Y. S., Hou, A. J., Zhu, G. F., Chen, Y. F., Sun, H. D. and Zhao, Q. S. (2004) Cytotoxic isoprenylated xanthones from Cudrania tricuspidata. Bioorg. Med. Chem. 12: 1947-1953 https://doi.org/10.1016/j.bmc.2004.01.030
- Hano, Y., Matsumoto, Y., Shinohara, K., Sun, J. Y. and Nomura, T. (1991) Structures of four new isoprenylated xanthones, cudraxanthones L, M, N, and O from Cudrania tricuspidata. Planta. Med. 57: 172-175 https://doi.org/10.1055/s-2006-960059
- Groweiss, A., Cardellina, J. H. and Boyd, M. R. (2000) HIV-inhibitory prenylated xanthones and flavones from Maclura tinctoria. J. Nat. Prod. 63: 1537-1539 https://doi.org/10.1021/np000175m
- Tiemersma, E. W., Bronzwaer, S. L., Lytikainen, O., Degener, J. E., Schrijnemakers, P., Bruinsma, N., Monen, J., Witte, W. and Grundman, H. (2004) Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002. Emerg. Infect. Dis. 10: 1627-1634 https://doi.org/10.3201/eid1009.040069
- Jennison, A. V. and Verma, N. K. (2004) Shigella flexneri infection: pathogenesis and vaccine development. FEMS Microbiol. Rev. 28: 43-58 https://doi.org/10.1016/j.femsre.2003.07.002
- Mead, P. S. and Griffin, P. M. (1998) Escherichia coli O157:H7. Lancet 352: 1207-1212 https://doi.org/10.1016/S0140-6736(98)01267-7
- Jin, L. Z., Samuel, K. B., Ronald, R. M. and Andrew, A. F. (1998) In vitro inhibition of adhesion of enterotoxigenic Esxherichia coli K88 to piglet intestinal mucus by egg-yolk antibodies. FEMS Immunol. Med. Mic. 21: 313-321 https://doi.org/10.1111/j.1574-695X.1998.tb01179.x